[Cases of lethal midline granuloma (polymorphic reticulosis) at our department in a recent 10-year period]. 1993

C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
Department of Otolaryngology, Osaka Prefectural General Hospital.

We had 18 patients (15 males and 3 females) with lethal midline granuloma (polymorphic reticulosis) in the period from 1981 to 1990. This number was about 5.6% of the total number of patients with malignant head and neck tumors that we encountered during this period. An average of 9.1 months separated the first appearance of disease and the beginning of treatment. Most of the 18 patients underwent both radiation therapy and chemotherapy (COP, CHOP, MACOP-B), but, since their disease had reached an advanced stage, 3 underwent radiation therapy only, 3 underwent chemotherapy only, and 1 received no radical therapy at all. Of the 18 patients, 13 died of the disease. In of 6 of these, the disease was confined to the local lesion. The 5-year cumulative survival rate was 15.7% (Kaplan-Meier). Fourteen autopsy studies revealed that tumor cells had invaded the liver (92.8%), lung (92.8%) and spleen (71.4%) and in all cases it was in leukemic patterns. Fifteen cases were studied for tumor surface marker phenotype, but none was found to be positive for L26, CD43, Leu M1 (CD15), or MAC 387. Five cases were positive for UCHL-1 (CD45RO) and 10 cases were positive for lysozyme. All cases were positive for Ki-1 (CD30).

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009669 Nose Neoplasms Tumors or cancer of the NOSE. Cancer of Nose,Nasal Neoplasms,Nose Cancer,Cancer of the Nose,Nasal Cancer,Neoplasms, Nose,Cancer, Nasal,Cancer, Nose,Cancers, Nasal,Cancers, Nose,Nasal Cancers,Nasal Neoplasm,Neoplasm, Nasal,Neoplasm, Nose,Neoplasms, Nasal,Nose Cancers,Nose Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006103 Granuloma, Lethal Midline A condition that is characterized by inflammation, ulceration, and perforation of the nose and the PALATE with progressive destruction of midline facial structures. This syndrome can be manifested in several diseases including the nasal type of EXTRANODAL NK-T-CELL LYMPHOMA and GRANULOMATOSIS WITH POLYANGIITIS. Granuloma Gangraenescens,Lethal Midline Granuloma,Polymorphic Reticulosis,Granulomas, Lethal Midline,Lethal Midline Granulomas,Midline Granuloma, Lethal,Midline Granulomas, Lethal,Polymorphic Reticuloses,Reticuloses, Polymorphic,Reticulosis, Polymorphic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
July 1976, The Laryngoscope,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
April 1994, Japanese journal of cancer research : Gann,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
April 1969, Cancer,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
January 1981, Virchows Archiv. A, Pathological anatomy and histology,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
January 1975, Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
June 1994, Cancer,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
August 1988, Cancer,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
February 2000, Chang Gung medical journal,
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
January 1999, Revista da Associacao Medica Brasileira (1992),
C Hatta, and M Ishida, and T Matsumoto, and Y Sugiyama, and N Makino, and K Kotoh
January 1992, Dakar medical,
Copied contents to your clipboard!